Gene Regulation by Antitumor
RACGAP1
antitumor
miR-204-5p
microRNA
pancreatic ductal adenocarcinoma
pathogenesis
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
07 Mar 2019
07 Mar 2019
Historique:
received:
15
01
2019
revised:
03
03
2019
accepted:
04
03
2019
entrez:
15
3
2019
pubmed:
15
3
2019
medline:
15
3
2019
Statut:
epublish
Résumé
Previously, we established a microRNA (miRNA) expression signature in pancreatic ductal adenocarcinoma (PDAC) tissues using RNA sequencing and found significantly reduced expression of
Identifiants
pubmed: 30866526
pii: cancers11030327
doi: 10.3390/cancers11030327
pmc: PMC6468488
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Japan Society for the Promotion of Science
ID : 18K16322
Organisme : Japan Society for the Promotion of Science
ID : 18K08687
Organisme : Japan Society for the Promotion of Science
ID : 18K08626
Organisme : Japan Society for the Promotion of Science
ID : 17H04285
Organisme : Japan Society for the Promotion of Science
ID : 16H05462(B)
Organisme : Japan Society for the Promotion of Science
ID : 15K10801
Références
Nat Rev Cancer. 2004 Jan;4(1):45-60
pubmed: 14681689
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
Trends Cell Biol. 2004 Jul;14(7):377-85
pubmed: 15246431
N Engl J Med. 2005 Oct 27;353(17):1768-71
pubmed: 16251533
Cell. 2007 Jun 1;129(5):865-77
pubmed: 17540168
Cell. 2009 Jan 23;136(2):215-33
pubmed: 19167326
N Engl J Med. 2010 Apr 29;362(17):1605-17
pubmed: 20427809
Clin Cancer Res. 2011 Sep 15;17(18):6040-51
pubmed: 21825042
Nature. 2012 Nov 15;491(7424):399-405
pubmed: 23103869
Clin Chem. 2013 Jan;59(1):41-6
pubmed: 23136253
Mol Cancer. 2013 Sep 11;12(1):105
pubmed: 24025188
Gastric Cancer. 2015 Jan;18(1):84-92
pubmed: 24615626
Int J Cancer. 2015 Mar 1;136(5):E359-86
pubmed: 25220842
Br J Cancer. 2014 Dec 9;111(12):2316-27
pubmed: 25412236
Carcinogenesis. 2015 Mar;36(3):346-54
pubmed: 25568185
Int J Urol. 2015 Mar;22(3):242-52
pubmed: 25599923
Int J Cancer. 2015 Nov 1;137(9):2175-83
pubmed: 25940397
Mol Cancer Ther. 2015 Aug;14(8):1939-50
pubmed: 26018753
Nat Genet. 2015 Aug;47(8):911-6
pubmed: 26098869
Oncotarget. 2015 Oct 20;6(32):33805-22
pubmed: 26393880
Mol Med Rep. 2015 Dec;12(6):8003-9
pubmed: 26461269
Lancet. 2016 Jul 2;388(10039):73-85
pubmed: 26830752
Oncotarget. 2016 Apr 26;7(17):23263-81
pubmed: 26993610
Clin Cancer Res. 2016 Sep 15;22(18):4676-86
pubmed: 27121792
J Hum Genet. 2017 Jan;62(1):33-40
pubmed: 27251005
Oncotarget. 2016 Oct 11;7(41):66328-66343
pubmed: 27579533
Oncotarget. 2017 Feb 21;8(8):14147-14157
pubmed: 27829225
Cancer Sci. 2017 Jan;108(1):124-135
pubmed: 27862697
Cancer Med. 2017 Jan;6(1):275-287
pubmed: 28028927
Oncotarget. 2017 May 2;8(18):29540-29557
pubmed: 28199974
J Cancer. 2017 Jul 21;8(12):2356-2368
pubmed: 28819440
Cancer Metastasis Rev. 2017 Sep;36(3):525-545
pubmed: 28836104
Oncotarget. 2017 May 29;8(32):53180-53193
pubmed: 28881803
Oncotarget. 2017 Jul 26;8(41):70097-70115
pubmed: 29050264
Cancer Sci. 2018 Jan;109(1):84-93
pubmed: 29095547
Cancer Sci. 2018 Apr;109(4):1239-1253
pubmed: 29417701
Nat Commun. 2018 Feb 8;9(1):556
pubmed: 29422604
Cancer Sci. 2018 Jun;109(6):2013-2026
pubmed: 29660218
Biomed Pharmacother. 2018 Jul;103:782-789
pubmed: 29684857
Cancer Sci. 2018 Sep;109(9):2919-2936
pubmed: 29968393
Oncogenesis. 2018 Jul 6;7(7):52
pubmed: 29976975
Oncotarget. 2018 Jun 22;9(48):28849-28865
pubmed: 29988949
Int J Urol. 2018 Nov;25(11):953-965
pubmed: 30153702
J Hum Genet. 2018 Dec;63(12):1197-1210
pubmed: 30228364
Mol Oncol. 2019 Feb;13(2):322-337
pubmed: 30444038